JP2022504826A5 - - Google Patents
Info
- Publication number
- JP2022504826A5 JP2022504826A5 JP2021520222A JP2021520222A JP2022504826A5 JP 2022504826 A5 JP2022504826 A5 JP 2022504826A5 JP 2021520222 A JP2021520222 A JP 2021520222A JP 2021520222 A JP2021520222 A JP 2021520222A JP 2022504826 A5 JP2022504826 A5 JP 2022504826A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- chain variable
- variable domain
- heavy chain
- light chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862744059P | 2018-10-10 | 2018-10-10 | |
| US62/744,059 | 2018-10-10 | ||
| PCT/CA2019/051448 WO2020073131A1 (en) | 2018-10-10 | 2019-10-10 | Antibody constructs binding 4-1bb and tumor-associated antigens and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022504826A JP2022504826A (ja) | 2022-01-13 |
| JP2022504826A5 true JP2022504826A5 (cg-RX-API-DMAC7.html) | 2022-10-18 |
| JP7596263B2 JP7596263B2 (ja) | 2024-12-09 |
Family
ID=70164178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021520222A Active JP7596263B2 (ja) | 2018-10-10 | 2019-10-10 | 4-1bb及び腫瘍関連抗原に結合する抗体構築物ならびにその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230052369A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3864051A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7596263B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR20260080511A (cg-RX-API-DMAC7.html) |
| CN (2) | CN112996809A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019356806B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021006784A2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA3113539A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021004058A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020073131A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3146977A1 (en) * | 2020-04-15 | 2021-10-21 | Zymeworks Inc. | Antibody constructs binding 4-1bb and folate receptor alpha and uses thereof |
| AU2021268340A1 (en) | 2020-05-06 | 2022-12-08 | Dragonfly Therapeutics, Inc. | Proteins binding NKG2D, CD16 and CLEC12A |
| CN112794911B (zh) * | 2021-04-14 | 2021-08-03 | 上海偌妥生物科技有限公司 | 人源化抗叶酸受体1抗体及其应用 |
| AU2022260298A1 (en) * | 2021-04-23 | 2023-11-02 | Shanghai Henlius Biotech, Inc. | Anti-gpc3 antibodies, multispecific antibodies and methods of use |
| CN116769041A (zh) * | 2022-03-10 | 2023-09-19 | 合肥瀚科迈博生物技术有限公司 | 靶向msln和4-1bb的双特异性抗体及其应用 |
| JP2025529310A (ja) * | 2022-09-06 | 2025-09-04 | ティージェイ バイオファーマ (シャンハイ) カンパニー, リミテッド | 多特異性構築物およびその使用 |
| KR20250089528A (ko) * | 2022-10-18 | 2025-06-18 | 투불리스 게엠베하 | 신규한 napi2b 항체를 함유하는 신규한 항체 약물 접합체, 치료 방법 및 이의 용도 |
| WO2025131027A1 (en) * | 2023-12-21 | 2025-06-26 | Lanova Medicines Development Co., Ltd. | Anti-slc34a2/anti-4-1bb antibodies and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2014509841A (ja) * | 2011-01-18 | 2014-04-24 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 癌を治療するための組成物および方法 |
| CN122399016A (zh) * | 2014-03-15 | 2026-07-17 | 诺华股份有限公司 | 使用嵌合抗原受体治疗癌症 |
| BR112018071612A2 (pt) * | 2016-04-22 | 2019-02-19 | Alligator Bioscience Ab | polipeptídeos biespecíficos inovadores contra cd137 |
| DK3529269T3 (da) * | 2016-10-19 | 2026-02-23 | Invenra Inc | Antistof-konstruktioner |
| BR112019017628A2 (pt) * | 2017-02-24 | 2020-07-07 | Macrogenics, Inc. | molécula de ligação a cd137 x ta, composições farmacêuticas, uso da molécula de ligação a cd137 x ta, molécula de ligação a cd137, uso da molécula de ligação a cd137, molécula de ligação a her2/neu, uso da molécula de ligação a her2/neu, e uso de uma composição |
-
2019
- 2019-10-10 EP EP19871359.6A patent/EP3864051A4/en active Pending
- 2019-10-10 CN CN201980066726.6A patent/CN112996809A/zh active Pending
- 2019-10-10 KR KR1020267016214A patent/KR20260080511A/ko active Pending
- 2019-10-10 BR BR112021006784-1A patent/BR112021006784A2/pt unknown
- 2019-10-10 KR KR1020217011608A patent/KR20210076918A/ko active Pending
- 2019-10-10 CN CN202511697951.3A patent/CN121758617A/zh active Pending
- 2019-10-10 CA CA3113539A patent/CA3113539A1/en active Pending
- 2019-10-10 WO PCT/CA2019/051448 patent/WO2020073131A1/en not_active Ceased
- 2019-10-10 JP JP2021520222A patent/JP7596263B2/ja active Active
- 2019-10-10 CA CA3302495A patent/CA3302495A1/en active Pending
- 2019-10-10 MX MX2021004058A patent/MX2021004058A/es unknown
- 2019-10-10 AU AU2019356806A patent/AU2019356806B2/en active Active
-
2021
- 2021-04-09 US US17/226,834 patent/US20230052369A1/en active Pending